Want to join the conversation?
Factory automation equipment maker $EMR reported a 34% drop in 1Q16 earnings due to volume deleverage and unfavorable mix as well as lower oil prices. Net income fell to $349MM or $0.53 per share from $525MM or $0.75 per share last year. Sales slid 16% to $4.71Bil. Adjusted EPS decreased by 25% to $0.56.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?